Organon OGN
NYSE OGN
$13.73 -0.01 (-0.04%)
As of: Aug 21, 2026 · 11:57 AM EDT

Organon (OGN) EBT Margin (2020 - 2026)

Organon (OGN) posted quarterly EBT Margin of 11.75% for Q2 2026, down 262.0% year-over-year from 7.25% in Q2 2025, and down 19.49% on a QoQ basis from 14.59% in Q1 2026.

Organon (OGN) EBT Margin (2020 - 2026) Analysis & Trends

Organon has reported EBT Margin for 7 years, with the latest figure at 11.75% in Q2 2026.

  • EBT Margin for Q2 2026 came in at 11.75%, down 262.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 8.01% (down 259.0% YoY), and the FY2025 annual result was 6.84%, down 577.0% from the prior year.
  • EBT Margin eased to 11.75% in Q2 2026, from 14.59% in the prior quarter.
  • Over five years, EBT Margin peaked at 37.85% in Q4 2022 and troughed at 9.82% in Q4 2025.
  • A 5-year average of 13.8% and a median of 14.57% in 2024 frame the typical range for EBT Margin.
  • The widest annual swing landed in 2022, when EBT Margin jumped 2312 bps; it then slumped 3134 bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 37.85% in 2022, then plunged by 83 bps to 6.51% in 2023, then climbed by 25 bps to 8.1% in 2024, then sank by 221 bps to 9.82% in 2025, then soared by 220 bps to 11.75% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 11.75% in Q2 2026, 14.59% in Q1 2026, and 9.82% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 653.56 Bn 632.80 Bn 17.26 Bn 26.66%
2 AbbVie 469.72 Bn 463.15 Bn 12.70 Bn 25.18%
3 Merck 377.32 Bn 370.18 Bn 12.21 Bn -4.11%
4 Novartis Ag 302.80 Bn 295.11 Bn 11.24 Bn 29.63%
5 Astrazeneca 258.16 Bn 253.26 Bn 12.86 Bn 18.19%
6 Amgen 237.16 Bn 223.17 Bn 7.24 Bn 27.53%
7 Gilead Sciences 183.24 Bn 180.06 Bn 6.22 Bn -131.41%
8 Pfizer 160.63 Bn 148.93 Bn 10.94 Bn -4.34%
9 Gsk 106.06 Bn 101.89 Bn 8.24 Bn 4.21%
10 Organon 3.61 Bn 2.47 Bn 847.00 Mn 11.75%

Historic Data

Download Data
DateValue
Jun 30, 2026 11.75%
Mar 31, 2026 14.59%
Dec 31, 2025 -9.82%
Sep 30, 2025 15.17%
Jun 30, 2025 14.37%
Mar 31, 2025 6.68%
Dec 31, 2024 8.10%
Sep 30, 2024 13.08%
Jun 30, 2024 14.62%
Mar 31, 2024 14.55%
Dec 31, 2023 6.51%
Sep 30, 2023 5.27%
Jun 30, 2023 15.80%
Mar 31, 2023 15.28%
Dec 31, 2022 37.85%
Sep 30, 2022 18.35%
Jun 30, 2022 18.11%
Mar 31, 2022 28.21%
Dec 31, 2021 14.72%
Sep 30, 2021 24.31%